Advertisement

Danaher Corporation DHR-PB

Set alert

Price alert · DHR-PB

All alert types
1,261.26 0.00 0.00%

At close · Apr 14

1,260.39 Day range 1,265.99
1,199.99 52-week range 1,521.85
Open
1,263.90
Prev close
1,261.26
Mkt cap
916.76B
Vol
152.33K
Avg vol
12.97K
EPS
8.64
P/E
146.01
Div yield
3.93%
More statistics
Low
1,260.39
High
1,265.99
Forward P/E
0.00
Beta
0.80
Short ratio
5.25
Inst. own
117.39%
Dividend
50.00
Ex-div date
Mar 29, 2023
50-d avg
1,270.85
200-d avg
1,362.89
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for DHR-PB has not been loaded yet. Try again in a moment.

Key statistics

Market cap
0
Enterprise value
935.34B
Trailing P/E
146.01
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
18.97
EPS (TTM)
8.64
Beta
0.80
Dividend yield
3.93%
Payout ratio
0.00%
Profit margin
22.91%
Revenue (TTM)
31.47B
Revenue growth
2.70%
Free cash flow
5.59B
Total cash
5.99B
Total debt
20.74B
Return on equity
15.13%
Shares outstanding
0
Short % of float
0.00%
50-day average
1,270.85
200-day average
1,362.89

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
danaher.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on DHR-PB — it syncs with the Stock Master app.

Institution ownership

DHR-PB institution ownership
Holder% heldSharesValueReported
Mackay Shields LLC0.00%85,202107.46MDec 30, 2022
Lord, Abbett & Co. LLC0.00%96,973122.31MDec 30, 2022
Franklin Resources, Inc.0.00%81,285102.52MDec 30, 2022
Capital Research Global Investors0.00%325,956411.12MDec 30, 2022
Capital World Investors0.00%229,302289.21MDec 30, 2022
Blackrock Inc.0.00%157,941199.20MDec 30, 2022

Fund ownership

DHR-PB fund ownership
Holder% heldSharesValueReported
Putnam Large Cap Value Fund0.00%73,79993.08MOct 30, 2022
Lord Abbett Affiliated Fund0.00%87,000109.73MOct 30, 2022
American Mutual Fund Inc0.00%162,573205.05MDec 30, 2022
American Funds Insurance Ser-Growth/Income Fund0.00%123,957156.34MDec 30, 2022
Washington Mutual Investors Fund0.00%107,417135.48MDec 30, 2022
Investment Company Of America0.00%48,69361.41MDec 30, 2022
Advertisement